Article
Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?
Current opinion in obstetrics & gynecology - 1 Feb 2024
Kamara Daniella, Silver Erica, Niell-Swiller Mariana
Abstract excerpt
PURPOSE OF REVIEW: Hereditary cancer risk assessment and counseling have become integral in oncology care, especially in breast and gynecologic malignancies where genetic test results impact management. However, a large number of patients who could benefit from genetic testing are not getting tested. As such, genetic risk assessment and counseling methods have had to evolve to meet the needs of this expanding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
